Strongbridge Biopharma plc to Present at the JMP Securities Life Sciences Conference

DUBLIN, Ireland and TREVOSE, Pa., June 06, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, SBBP, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that management will present at the JMP Securities Life Sciences Conference taking place June 20-21, 2018 at the St. Regis in New York, NY.

Matthew Pauls, president and chief executive officer of Strongbridge Biopharma, will provide a corporate overview on Wednesday, June 20 at 12:00p.m. E.T. The presentation will be webcast live and archived on the "Events & Presentations" page in the investor section of the Company's website at www.strongbridgebio.com.

About Strongbridge Biopharma

Strongbridge Biopharma is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. Strongbridge's commercial portfolio within its rare neuromuscular and rare endocrine franchises includes KEVEYIS® (dichlorphenamide), the first and only FDA-approved treatment for hyperkalemic, hypokalemic, and related variants of primary periodic paralysis, and MACRILEN™ (macimorelin), the first and only FDA-approved oral drug indicated for the diagnosis of adult growth hormone deficiency. The Company's rare endocrine franchise also includes a clinical-stage pipeline of therapies: RECORLEV™ (levoketoconazole), a cortisol synthesis inhibitor currently being studied for the treatment of endogenous Cushing's syndrome, and veldoreotide, a next-generation somatostatin analog being investigated for the treatment of acromegaly and potential additional applications in other conditions amenable to somatostatin receptor activation.

Contacts:

Corporate and Media Relations

Elixir Health Public Relations

Lindsay Rocco

+1 862-596-1304

lrocco@elixirhealthpr.com

Investor Relations

United States:

Solebury Trout

Marcy Nanus

+1 646-378-2927

mnanus@soleburytrout.com

Europe:

First House

Geir Arne Drangeid

+47 913 10 458

strongbridgebio@firsthouse.no

USA

900 Northbrook Drive

Suite 200

Trevose, PA 19053

Tel. +1 610-254-9200

Fax. +1 215-355-7389